Differences in Brain-Derived Neurotrophic Factor and Matrix Metalloproteinase-9 between Appropriate Neonates between Normal Birth Weight and Intrauterine Growth Restriction
Authors:
Open Access
- 15 March 2019
- journal article
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 7 (5) , 736-741
Abstract
BACKGROUND: Intrauterine Growth Restriction (IUGR) was defined as the growth of the fetus less than its normal potential growth due to genetic and environmental factors. One of the most widely believed causes of IUGR was impaired uteroplacental mechanism from mother to fetus. Furthermore, factor which was thought to affect placental growth was due to the influence of Brain-Derived Neurotrophic Factor (BDNF) and Matrix Metalloproteinase (MMP-9) which play an important role in angiogenesis. AIM: This study aims to determine differences in Brain-Derived Neurotrophic Factor (BDNF) and moderately mature Matrix Metalloproteinase (MMP-9) between normal birth weight and intrauterine growth restriction. MATERIAL AND METHODS: The study design was a cross-sectional study at four hospitals in Padang city from August 2017-January 2018. The sample of this study was umbilical cord blood of appropriate gestational age neonate with normal birth weight (31 neonates) and IUGR (31 neonates) by consecutive sampling, samples taken from mothers who meet inclusion criteria. BDNF and MMP-9 levels were analysed by ELISA. The differences between normal birth weight and IUGR test were followed by unpaired T-test. RESULTS: The results showed that BDNF levels in normal neonates was 1.58 ± 0.23 ng/ml and in IUGR neonates were 1.25 ± 0.35 ng/ml (p = 0.001). MMP-9 levels in normal neonates was 1.09 ± 0.20 ng/ml and in IUGR neonates were 1.25 ± 0.35 (p = 0.03). CONCLUSION: The conclusion of this study was BDNF of moderately mature neonates was significantly higher in normal birth weight compared to intrauterine growth restriction, and the moderately high MMP-9 neonates were significantly higher in intrauterine growth restriction compared with normal birth weight.Keywords
This publication has 14 references indexed in Scilit:
- Differences in brain-derived neurotrophic factor between neonates born to mothers with normal and low ferritin2018
- Serum brain-derived neurotrophic factor (BDNF) across pregnancy and postpartum: Associations with race, depressive symptoms, and low birth weightPsychoneuroendocrinology, 2016
- Association of decreased serum brain-derived neurotrophic factor (BDNF) concentrations in early pregnancy with antepartum depressionBMC Psychiatry, 2015
- Low levels of tissue inhibitor of metalloproteinase-2 at birth may be associated with subsequent development of bronchopulmonary dysplasia in preterm infantsKorean Journal of Pediatrics, 2015
- Neurotrophins: Role in adverse pregnancy outcomeInternational Journal of Developmental Neuroscience, 2014
- Brain-derived neurotrophic factor and ciliary neurotrophic factor in maternal plasma and umbilical cord blood from pre-eclamptic and physiological pregnanciesJournal of Obstetrics and Gynaecology, 2013
- Placental BDNF/TrkB Signaling System is Modulated by Fetal Growth Disturbances in Rat and HumanPlacenta, 2010
- Regulation of preimplantation embryo development by brain-derived neurotrophic factorDevelopmental Biology, 2007
- Brain-Derived Neurotrophic Factor Activation of TrkB Induces Vascular Endothelial Growth Factor Expression via Hypoxia-Inducible Factor-1α in Neuroblastoma CellsCancer Research, 2006
- The impact of age, weight and gender on BDNF levels in human platelets and plasmaNeurobiology of Aging, 2005